Barclays’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-95,436
| Closed | -$9.26M | – | 7139 |
|
|
2019
Q3 | $9.26M | Sell |
95,436
-49,975
| -34% | -$5M | 0.01% | 1341 |
|
|
2019
Q2 | $14.9M | Buy |
145,411
+91,429
| +169% | +$9.87M | 0.01% | 1104 |
|
|
2019
Q1 | $6.15M | Buy |
53,982
+40,230
| +293% | +$2.96M | ﹤0.01% | 1515 |
|
|
2018
Q4 | $538K | Sell |
13,752
-4,742
| -26% | -$206K | ﹤0.01% | 3736 |
|
|
2018
Q3 | $1.01M | Buy |
18,494
+12,982
| +236% | +$888K | ﹤0.01% | 3612 |
|
|
2018
Q2 | $457K | Sell |
5,512
-10,559
| -66% | -$815K | ﹤0.01% | 4036 |
|
|
2018
Q1 | $1.07M | Buy |
16,071
+11,687
| +267% | +$675K | ﹤0.01% | 3133 |
|
|
2017
Q4 | $225K | Buy |
4,384
+3,763
| +606% | +$270K | ﹤0.01% | 4584 |
|
|
2017
Q3 | $55K | Sell |
621
-1,141
| -65% | -$86.6K | ﹤0.01% | 5308 |
|
|
2017
Q2 | $105K | Sell |
1,762
-2,548
| -59% | -$142K | ﹤0.01% | 4872 |
|
|
2017
Q1 | $228K | Buy |
4,310
+1,425
| +49% | +$84.6K | ﹤0.01% | 4180 |
|
|
2016
Q4 | $144K | Buy |
2,885
+802
| +39% | +$43K | ﹤0.01% | 4481 |
|
|
2016
Q3 | $124K | Sell |
2,083
-4,372
| -68% | -$252K | ﹤0.01% | 4352 |
|
|
2016
Q2 | $330K | Buy |
6,455
+4,824
| +296% | +$206K | ﹤0.01% | 3552 |
|
|
2016
Q1 | $47K | Buy |
1,631
+1,462
| +865% | +$46.1K | ﹤0.01% | 4814 |
|
|
2015
Q4 | $8K | Buy |
169
+127
| +302% | +$6.66K | ﹤0.01% | 5474 |
|
|
2015
Q3 | $2K | Sell |
42
-3,571
| -99% | -$186K | ﹤0.01% | 6430 |
|
|
2015
Q2 | $217K | Buy |
3,613
+3,507
| +3,308% | +$232K | ﹤0.01% | 4089 |
|
|
2015
Q1 | $8K | Buy |
+106
| New | +$6.11K | ﹤0.01% | 6374 |
|